Annual Total Liabilities
$242.65 M
-$15.13 M-5.87%
May 26, 2024
Summary
- As of February 12, 2025, LFCR annual total liabilities is $242.65 million, with the most recent change of -$15.13 million (-5.87%) on May 26, 2024.
- During the last 3 years, LFCR annual total liabilities has fallen by -$57.49 million (-19.16%).
- LFCR annual total liabilities is now -21.80% below its all-time high of $310.27 million, reached on May 1, 2020.
Performance
LFCR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$239.94 M
-$10.82 M-4.32%
November 24, 2024
Summary
- As of February 12, 2025, LFCR quarterly total liabilities is $239.94 million, with the most recent change of -$10.82 million (-4.32%) on November 24, 2024.
- Over the past year, LFCR quarterly total liabilities has increased by +$11.38 million (+4.98%).
- LFCR quarterly total liabilities is now -22.67% below its all-time high of $310.27 million, reached on May 1, 2020.
Performance
LFCR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LFCR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | +5.0% |
| 3 y3 years | -19.2% | +5.0% |
| 5 y5 years | -2.5% | -20.3% |
LFCR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.2% | +29.8% | -7.4% | +32.2% |
| 5 y | 5-year | -21.8% | +29.8% | -22.7% | +32.2% |
| alltime | all time | -21.8% | >+9999.0% | -22.7% | >+9999.0% |
Lifecore Biomedical Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $239.94 M(-4.3%) |
| Aug 2024 | - | $250.76 M(+3.3%) |
| May 2024 | $242.65 M(-5.9%) | $242.65 M(+6.2%) |
| Feb 2024 | - | $228.56 M(-6.5%) |
| Nov 2023 | - | $244.40 M(-5.7%) |
| Aug 2023 | - | $259.18 M(+0.5%) |
| May 2023 | $257.77 M(+37.9%) | $257.77 M(+27.6%) |
| Feb 2023 | - | $201.95 M(-1.4%) |
| Nov 2022 | - | $204.91 M(+8.5%) |
| Aug 2022 | - | $188.90 M(+1.1%) |
| May 2022 | $186.88 M(-37.7%) | $186.88 M(+3.0%) |
| Feb 2022 | - | $181.51 M(-31.7%) |
| Nov 2021 | - | $265.92 M(+5.6%) |
| Aug 2021 | - | $251.75 M(-16.1%) |
| May 2021 | $300.14 M(-3.3%) | - |
| May 2021 | - | $300.14 M(-1.7%) |
| Feb 2021 | - | $305.20 M(+5.2%) |
| Nov 2020 | - | $290.22 M(+1.8%) |
| Aug 2020 | - | $285.02 M(-8.1%) |
| May 2020 | $310.27 M(+24.6%) | $310.27 M(+2.6%) |
| Feb 2020 | - | $302.39 M(+0.5%) |
| Nov 2019 | - | $300.92 M(+7.0%) |
| Aug 2019 | - | $281.19 M(+13.0%) |
| May 2019 | $248.95 M(+63.6%) | $248.95 M(+7.5%) |
| Feb 2019 | - | $231.52 M(+46.5%) |
| Nov 2018 | - | $158.08 M(+5.7%) |
| Aug 2018 | - | $149.52 M(-1.7%) |
| May 2018 | $152.14 M(+16.6%) | $152.14 M(+12.1%) |
| Feb 2018 | - | $135.69 M(-7.4%) |
| Nov 2017 | - | $146.60 M(+8.0%) |
| Aug 2017 | - | $135.80 M(+4.1%) |
| May 2017 | $130.46 M(+0.1%) | $130.46 M(+6.9%) |
| Feb 2017 | - | $122.00 M(+0.2%) |
| Nov 2016 | - | $121.79 M(-4.0%) |
| Aug 2016 | - | $126.82 M(-2.7%) |
| May 2016 | $130.30 M(+3.1%) | $130.30 M(+6.7%) |
| Feb 2016 | - | $122.07 M(-9.2%) |
| Nov 2015 | - | $134.43 M(+13.4%) |
| Aug 2015 | - | $118.58 M(-6.2%) |
| May 2015 | $126.36 M(+16.1%) | $126.36 M(+1.2%) |
| Feb 2015 | - | $124.80 M(-4.0%) |
| Nov 2014 | - | $129.99 M(+9.8%) |
| Aug 2014 | - | $118.41 M(+8.8%) |
| May 2014 | $108.86 M(-1.5%) | $108.86 M(+1.6%) |
| Feb 2014 | - | $107.14 M(-4.3%) |
| Nov 2013 | - | $111.99 M(+6.3%) |
| Aug 2013 | - | $105.36 M(-4.7%) |
| May 2013 | $110.53 M(-12.4%) | $110.53 M(+2.0%) |
| Feb 2013 | - | $108.32 M(-1.8%) |
| Nov 2012 | - | $110.35 M(-2.1%) |
| Aug 2012 | - | $112.76 M(-10.6%) |
| May 2012 | $126.13 M(+83.9%) | $126.13 M(+103.7%) |
| Feb 2012 | - | $61.94 M(-7.5%) |
| Nov 2011 | - | $66.99 M(-0.8%) |
| Aug 2011 | - | $67.55 M(-1.5%) |
| May 2011 | $68.59 M | $68.59 M(+1.8%) |
| Feb 2011 | - | $67.39 M(-2.4%) |
| Nov 2010 | - | $69.06 M(-1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2010 | - | $70.06 M(+3.4%) |
| May 2010 | $67.72 M(+157.5%) | $67.72 M(+162.7%) |
| Feb 2010 | - | $25.78 M(-7.8%) |
| Nov 2009 | - | $27.94 M(-16.7%) |
| Aug 2009 | - | $33.56 M(+27.6%) |
| May 2009 | $26.30 M(-23.9%) | $26.30 M(+4.7%) |
| Feb 2009 | - | $25.11 M(-12.1%) |
| Nov 2008 | - | $28.58 M(-10.1%) |
| Aug 2008 | - | $31.79 M(-8.1%) |
| May 2008 | $34.57 M(+18.0%) | $34.57 M(+35.9%) |
| Feb 2008 | - | $25.43 M(-2.9%) |
| Nov 2007 | - | $26.20 M(-11.1%) |
| Aug 2007 | - | $29.49 M(+0.7%) |
| May 2007 | $29.30 M(-9.0%) | $29.30 M(+3.4%) |
| Feb 2007 | - | $28.33 M(-24.9%) |
| Nov 2006 | - | $37.75 M(+39.3%) |
| Aug 2006 | - | $27.10 M(-15.8%) |
| May 2006 | $32.20 M(+21.3%) | $32.20 M(-18.2%) |
| Feb 2006 | - | $39.39 M(+7.8%) |
| Nov 2005 | - | $36.52 M(+43.3%) |
| Aug 2005 | - | $25.49 M(-4.0%) |
| May 2005 | $26.55 M(-11.2%) | $26.55 M(-18.0%) |
| Feb 2005 | - | $32.38 M(-4.0%) |
| Nov 2004 | - | $33.74 M(+9.0%) |
| Aug 2004 | - | $30.95 M(+3.5%) |
| May 2004 | $29.91 M(-21.2%) | $29.91 M(-20.8%) |
| Feb 2004 | - | $37.77 M(-3.2%) |
| Nov 2003 | - | $39.02 M(+20.6%) |
| Aug 2003 | - | $32.36 M(-13.9%) |
| May 2003 | $37.93 M(-24.5%) | - |
| Apr 2003 | - | $37.57 M(-22.4%) |
| Jan 2003 | - | $48.42 M(-3.7%) |
| Oct 2002 | $50.26 M(-27.4%) | $50.26 M(-3.4%) |
| Jul 2002 | - | $52.04 M(-6.5%) |
| Apr 2002 | - | $55.65 M(-25.9%) |
| Jan 2002 | - | $75.06 M(+8.4%) |
| Oct 2001 | $69.25 M(-7.3%) | $69.25 M(-6.3%) |
| Jul 2001 | - | $73.90 M(+0.7%) |
| Apr 2001 | - | $73.41 M(-8.5%) |
| Jan 2001 | - | $80.22 M(+7.4%) |
| Oct 2000 | $74.72 M(+739.6%) | $74.72 M(+0.1%) |
| Jul 2000 | - | $74.65 M(+11.9%) |
| Apr 2000 | - | $66.73 M(-2.4%) |
| Jan 2000 | - | $68.40 M(+668.5%) |
| Oct 1999 | $8.90 M(+2.3%) | $8.90 M(+43.5%) |
| Jul 1999 | - | $6.20 M(-7.5%) |
| Apr 1999 | - | $6.70 M(-50.0%) |
| Jan 1999 | - | $13.40 M(+54.0%) |
| Oct 1998 | $8.70 M(-40.4%) | $8.70 M(+210.7%) |
| Jul 1998 | - | $2.80 M(-24.3%) |
| Apr 1998 | - | $3.70 M(-65.1%) |
| Jan 1998 | - | $10.60 M(-27.4%) |
| Oct 1997 | $14.60 M(+711.1%) | $14.60 M(+21.7%) |
| Jul 1997 | - | $12.00 M(-6.3%) |
| Apr 1997 | - | $12.80 M(+700.0%) |
| Jan 1997 | - | $1.60 M(-11.1%) |
| Oct 1996 | $1.80 M | $1.80 M(+20.0%) |
| Jul 1996 | - | $1.50 M(-25.0%) |
| Apr 1996 | - | $2.00 M |
FAQ
- What is Lifecore Biomedical annual total liabilities?
- What is the all time high annual total liabilities for Lifecore Biomedical?
- What is Lifecore Biomedical annual total liabilities year-on-year change?
- What is Lifecore Biomedical quarterly total liabilities?
- What is the all time high quarterly total liabilities for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly total liabilities year-on-year change?
What is Lifecore Biomedical annual total liabilities?
The current annual total liabilities of LFCR is $242.65 M
What is the all time high annual total liabilities for Lifecore Biomedical?
Lifecore Biomedical all-time high annual total liabilities is $310.27 M
What is Lifecore Biomedical annual total liabilities year-on-year change?
Over the past year, LFCR annual total liabilities has changed by -$15.13 M (-5.87%)
What is Lifecore Biomedical quarterly total liabilities?
The current quarterly total liabilities of LFCR is $239.94 M
What is the all time high quarterly total liabilities for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly total liabilities is $310.27 M
What is Lifecore Biomedical quarterly total liabilities year-on-year change?
Over the past year, LFCR quarterly total liabilities has changed by +$11.38 M (+4.98%)